HHSE Board of Directors approves Uplisting / Registration Costs
Dear HHSE Friends, Followers & Shareholders: At a special meeting of the Board of Directors of Hannover House, Inc., held on Thursday, October 19 at 11:00-am, the Board voted unanimously to immediately reinstate the prior filing activities to register the company's stock shares with the Securities and Exchange Commission (Form 10). The Board also authorized the following budgetary expenditures - to be funded from ongoing cash flows - to promptly complete this task:
HHSE
Steps and Budget for UPLISTING
Item
Description
Amount
1
Internal Data Entry
$ 4,000
2
Completion of New Library Valuation
$ 20,000
3
Outside CPA Review
$ 4,500
4
PCAOB Audit
$ 50,000
5
Legal Review & Drafting
$ 6,500
6
Registration S.E.C. Filings & XBRL
$ 3,250
FIRST TIME - UPLIST REGISTRATION COSTS
$ 88,250
Ongoing Quarterly Auditor's Review
$ 5,000
Ongoing Quarterly Attorney's Review
$ 2,000
Annual Review of Q4 & prior 3-Q's
$ 20,000
Annual Attorney review and drafting
$ 3,000
ANNUAL MAINTENANCE TOTALS
$ 44,000
The one-time costs for the registration / uplist are estimated at $88,250. The ongoing (annualized) maintenance costs are estimated at $44,000 (inclusive of the Quarterly Reviews by the PCAOB Auditing firm, and the annual year-end report and legal review).
Based on current cash flow and resources - and considering the anticipated benefits to the Company and its shareholders for HHSE as a fully registered equity - the Board has authorized the immediate implementation of this plan and the authorization of these expenditures.
The Board believes that Fully Registered Shares will be more attractive to HHSE program suppliers and investors - as well as to institutional investors and hedge funds - and that pursuing these activities now is a good use of ongoing cash flows.
PRODUCT$-PRODUCT$-PRODUCT$. GETTING.GRACE-WHERE'S.THE.DRAGON-BLOODFEAST-DAISY.WINTERS-BATTLECREEK & OTHERS
GETTING GRACE - Hot on the heels of a major NYC Market festival SWEEP of all major awards, HHSE will be releasing this Faith-Based Comedy-Drama nationwide on February 10, 2018 - with an outreach campaign that includes mega-churches and a key-market BUS TOUR with star and director DANIEL ROEBUCK ("Matlock", "The Fugitive") to drive local market enthusiasm.
WHERE'S THE DRAGON - With the dissolution of the merger between HHSE and Crimson Forest, the company is finally cleared to revert back to the terms of the Dec. 2016 distribution agreement for this title. Accordingly, on February 3, 2018, this enchanting Animated Feature will be released to theatres in key markets, in advance of a May, 2018 Home Video and V.O.D. launch.
DEATH HOUSE - A wild horror-comedy from the producer of "Bill & Ted's Bogus Journey" is building strong horror-market enthusiasm from conventions and specialty sites. Opens Jan. 19, 2018 in a yet-undetermined (but significant) number of theatres!
CHOSEN - this impressive World War II thriller continues to get theatrical bookings in key USA markets, and now into CANADA (Toronto, Ottawa, Calgary and Vancouver)... watch for playdates in December and January.
BLOODFEAST - Now that the MPAA has approved our fourth edit for "R-Rating Status" - we can FINALLY get mainstream theatres to book this picture... watch for a roll-out beginning Nov. 17 into top markets (staggered over a 2-month period).
DAISY WINTERS - a much broader release (over 100 theatres) is set for December 1st for this awards-worthy drama featuring stunning performances from Brooke Shields and a breakout performance from young Sterling Jerins in the title role. The Media support has already begun, fueled by the Hannover House MEDIA DAY in NYC on Sept. 26, plus a special event premiere at the Regal Union Square (NYC) on Oct. 5. Already, Brooke has appeared on several national talk shows promoting DAISY WINTERS, including Bravo's WATCH WHAT HAPPENS LIVE and the highly rated TODAY SHOW on NBC. Much more to come, including major feature stories in People Magazine, USA Today, Closer, In-Touch, ACCESS HOLLYWOOD, EXTRA and E! TV.
BATTLECREEK - the acclaimed dramatic thriller from director ALISON EASTWOOD opens in two weeks (Nov. 3), in approx. 20 locations in key USA Markets. The film's primary star is BILL SKARSGARD, well-known from his current smash hit "IT" (he plays Pennywise, the scary clown), and his upcoming Stephen King TV series, "Castlerock." We have been fortunate to receive major media support for BATTLECREEK, including National TV show placements on: ACCESS HOLLYWOOD, EXTRA, E! and ENTERTAINMENT TONIGHT, and Alison Eastwood interview appearances on FOX AND FRIENDS, THE VIEW, TALK, GOOD DAY NY and HOME AND FAMILY. There will be an "Eastwood Family Screening Event" in Los Angeles on opening night (Nov. 3), which will be open to the public (and is expected to generate good attendance).
